Deep Learning for Fluorescein Angiography and Optical Coherence Tomography Macular Thickness Map Image Translation

Sponsor
Assiut University (Other)
Overall Status
Completed
CT.gov ID
NCT05105620
Collaborator
(none)
708
1
30.1
23.6

Study Details

Study Description

Brief Summary

Diabetic macular edema (DME) is one of the leading causes of visual impairment in patients with diabetes. Fluorescein angiography (FA) plays an important role in diabetic retinopathy (DR) staging and evaluation of retinal vasculature. However, FA is an invasive technique and does not permit the precise visualization of the retinal vasculature. Optical coherence tomography (OCT) is a non-invasive technique that has become popular in diagnosing and monitoring DR and its laser, medical, and surgical treatment. It provides a quantitative assessment of retinal thickness and location of edema in the macula. Automated OCT retinal thickness maps are routinely used in monitoring DME and its response to treatment. However, standard OCT provides only structural information and therefore does not delineate blood flow within the retinal vasculature. By combining the physiological information in FA with the structural information in the OCT, zones of leakage can be correlated to structural changes in the retina for better evaluation and monitoring of the response of DME to different treatment modalities. The occasional unavailability of either imaging modality may impair decision-making during the follow-up of patients with DME.

The problem of medical data generation particularly images has been of great interest, and as such, it has been deeply studied in recent years especially with the advent of deep convolutional neural networks(DCNN), which are progressively becoming the standard approach in most machine learning tasks such as pattern recognition and image classification. Generative adversarial networks (GANs) are neural network models in which a generation and a discrimination networks are trained simultaneously. Integrated network performance effectively generates new plausible image samples.

The aim of this work is to assess the efficacy of a GAN implementing pix2pix image translation for original FA to synthetic OCT color-coded macular thickness map image translation and the reverse (from original OCT color-coded macular thickness map to synthetic FA image translation).

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Fluorescein Angiography
  • Diagnostic Test: Optical coherence tomography

Study Design

Study Type:
Observational
Actual Enrollment :
708 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Bridging the Resources Gap: Deep Learning for Fluorescein Angiography and Optical Coherence Tomography Macular Thickness Map Image Translation
Actual Study Start Date :
Aug 1, 2018
Actual Primary Completion Date :
Feb 1, 2021
Actual Study Completion Date :
Feb 1, 2021

Outcome Measures

Primary Outcome Measures

  1. Fréchet inception distance (FID) score. [1 day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients from the retina clinic in Assiut University Hospital who had simultaneously undergone same-day FA and OCT with a diagnosis of confirmed or suspected DME.
Exclusion Criteria:
  • Significant media opacity that obscured the view of the fundus

  • OCT images with high signal-to-noise ratio expressed by the device as"TopQ image quality," below 60

  • Vitreoretinal interface disease distorting the OCT thickness map.

  • Patients with concurrent ocular conditions interfering with blood flow

  • Patients with uveitic diseases

  • High myopia of more than -8.0 diopters.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assiut University Assiut Egypt

Sponsors and Collaborators

  • Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Khaled Abdelazeem, Associate professor of Ophthalmology, Assiut University
ClinicalTrials.gov Identifier:
NCT05105620
Other Study ID Numbers:
  • 17300681
First Posted:
Nov 3, 2021
Last Update Posted:
Nov 5, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 5, 2021